HUTCHMED(00013.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 15.93 million, YoY decrease of 96.5%

NewTimeSpace News: July 30, 2026, HUTCHMED(00013.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 278.29 million, increased by 0.22% YoY; Net Profit stood at USD 16.24 million, YoY decrease of 96.43%; Profit Attributable to Shareholders stood at USD 15.93 million, YoY decrease of 96.5%; Basic Earnings Per Share (EPS) stood at US cents 2.

In terms of profitability, HUTCHMED Gross Profit changed from USD 110.1 million in the same period last year to USD 126.13 million in the current period, increased by USD 16.03 million; gross profit margin changed from 39.65% in the same period last year to 45.32% in the current period, increased by 5.67 percentage points; net profit changed from USD 455.56 million in the same period last year to USD 16.24 million in the current period, decreased by USD 439.31 million; net profit margin changed from 164.06% in the same period last year to 5.84% in the current period, decreased by 158.22 percentage points.

In terms of earnings quality, HUTCHMED Operating Profit changed from loss of USD 3.51 million in the same period last year to USD 869 thousand in the current period, increased by USD 4.38 million; Operating Profit Margin changed from -1.27% in the same period last year to 0.31% in the current period, increased by 1.58 percentage points; Net Cash Flow from Operating Activities changed from cash outflow of USD 72.89 million in the same period last year to cash inflow of USD 12.22 million in the current period, increased by USD 85.12 million; Ratio of Net Cash Flow from Operating Activities to Total Operating Revenue changed from -26.25% in the same period last year to 4.39% in the current period, increased by 30.64 percentage points.

In terms of financial soundness, HUTCHMED Debt-to-Asset Ratio changed from 30.07% in the same period last year to 26.58% in the current period, decreased by 3.49 percentage points; Total Equity changed from USD 1.242 billion in the same period last year to USD 1.275 billion in the current period, increased by USD 33.05 million; Cash and Cash Equivalents changed from USD 110.719 million in the same period last year to USD 106.557 million in the current period, decreased by USD 4.16 million; Current Liabilities changed from USD 342.35 million in the same period last year to USD 275.21 million in the current period, decreased by USD 67.14 million; Quick Ratio changed from 4.51 in the same period last year to 5.5 in the current period, increased by 0.99 percentage points.

In terms of R&D investment focus, HUTCHMED R&D Expenses changed from USD 71.99 million in the same period last year to USD 78.78 million in the current period, increased by USD 6.79 million; R&D to Total Revenue Ratio changed from 25.93% in the same period last year to 28.31% in the current period, increased by 2.38 percentage points.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.